dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Sethi, Sanjeev |
dc.contributor.author | Beck, Laurence |
dc.contributor.author | Glassock, Richard J. |
dc.contributor.author | Haas, Mark |
dc.contributor.author | De Vriese, An |
dc.contributor.author | Caza, Tiffany |
dc.contributor.author | Soler, María José |
dc.date.accessioned | 2023-11-23T10:32:44Z |
dc.date.available | 2023-11-23T10:32:44Z |
dc.date.issued | 2023-11 |
dc.identifier.citation | Sethi S, Beck LH, Glassock RJ, Haas M, De Vriese AS, Caza TN, et al. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification. Mayo Clin Proc. 2023 Nov;98(11):1671–84. |
dc.identifier.issn | 1942-5546 |
dc.identifier.uri | https://hdl.handle.net/11351/10642 |
dc.description | Consens; Nefropatia membranosa |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Mayo Clinic Proceedings;98(11) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Autoanticossos |
dc.subject | Glomerulonefritis - Diagnòstic |
dc.subject | Decisió de grup |
dc.subject.mesh | Glomerulonephritis, Membranous |
dc.subject.mesh | Consensus |
dc.subject.mesh | Autoantibodies |
dc.title | Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.mayocp.2023.08.006 |
dc.subject.decs | glomerulonefritis membranosa |
dc.subject.decs | consenso |
dc.subject.decs | autoanticuerpos |
dc.relation.publishversion | https://doi.org/10.1016/j.mayocp.2023.08.006 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sethi S] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. [Beck LH] Section of Nephrology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. [Glassock RJ] Department of Medicine, Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California, USA. [Haas M] Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA. [De Vriese AS] Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge, Brugge, Belgium. Department of Internal Medicine, Ghent University, Ghent, Belgium. [Caza TN] Arkana Laboratories, Little Rock, Arkansas, USA. [Soler MJ] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Referencia en Enfermedad, Glomerular Compleja del Sistema Nacional de Salud de España (CSUR), Barcelona, Spain |
dc.identifier.pmid | 37804268 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |